TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06281860

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatine Teva®
Description: PITHAC: Cisplatin (Cisplatine Teva®) at a dose between 7.5 and 70 mg/m2 of body surface at a temperature of 39±1°C

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatine Teva®
Description: PITHAC: Cisplatin (Cisplatine Teva®) at a dose between 7.5 and 70 mg/m2 of body surface at a temperature of 39±1°C

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatine Teva®
Description: PITHAC: Cisplatin (Cisplatine Teva®) at a dose between 7.5 and 70 mg/m2 of body surface at a temperature of 39±1°C

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatine Teva®
Description: PITHAC: Cisplatin (Cisplatine Teva®) at a dose between 7.5 and 70 mg/m2 of body surface at a temperature of 39±1°C
Study: NCT05940779

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise program
Description: The intervention is a therapeutic program composed of self-resisted strength exercises, balance training and exercises to improve posture.
Study: NCT04255446

Intervention type: DEVICE
Intervention: Thora3DiTM
Description: Not international

Intervention type: DEVICE
Intervention: Thora3DiTM
Description: Not international
Study: NCT04922476

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alflorex®
Description: Each probiotic capsule contains 1 x 10\^9 CFU of B. longum 35624® and corn starch, hydroxypropyl methyl cellulose and magnesium stearate.
Study: NCT05252364

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose expansion
Description: Part 2: Dose expansion~Daily oral dosage with the highest dose with acceptable toxicity (RP2D) based on data from Part 1.
Study: NCT05821803

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Using Insoles
Description: FootBalance %100 Control Orthopedic insoles used for 4 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using Insoles
Description: FootBalance %100 Control Orthopedic insoles used for 4 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Core Exercises
Description: 4 weeks including
Study: NCT05980624

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: oral nutrition supplement
Description: patients receive ONS 300kcal in daily basis
Study: NCT05925296

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: magnetic stimulation
Description: Patients in the Experimental group underwent ten sessions of double-site high frequency rTMS over the bilateral primary motor cortex of the lower leg and supplementary motor area, whereas patients in the Active Comparator group underwent ten sessions of single-site active magnetic stimulation with high frequency rTMS over the bilateral primary motor cortex of the lower leg. In addition, patients in the Sham Comparator group underwent 10 sessions of double sham rTMS on motor cortex.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: magnetic stimulation
Description: Patients in the Experimental group underwent ten sessions of double-site high frequency rTMS over the bilateral primary motor cortex of the lower leg and supplementary motor area, whereas patients in the Active Comparator group underwent ten sessions of single-site active magnetic stimulation with high frequency rTMS over the bilateral primary motor cortex of the lower leg. In addition, patients in the Sham Comparator group underwent 10 sessions of double sham rTMS on motor cortex.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: magnetic stimulation
Description: Patients in the Experimental group underwent ten sessions of double-site high frequency rTMS over the bilateral primary motor cortex of the lower leg and supplementary motor area, whereas patients in the Active Comparator group underwent ten sessions of single-site active magnetic stimulation with high frequency rTMS over the bilateral primary motor cortex of the lower leg. In addition, patients in the Sham Comparator group underwent 10 sessions of double sham rTMS on motor cortex.
Study: NCT05229302

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reframet IT
Description: The online intervention comprises 8 modules of cognitive behavioral therapy (CBT) delivered at schools by psychologists over 10 weeks. Contents: engagement and problem identification, emotional recognition and distress tolerance, identification of negative automatic thinking, help seeking and activity scheduling, problem solving, and cognitive restructuring, and a wrap up session. Two activities per module. Using a message board, the participant could communicate with research therapists who also check completed activities and respond with personalized messages. The face-to-face intervention comprises 4 CBT-based sessions to help the students in three aspects: i) close support and monitoring in case of an increase of symptomatology; ii) motivation to persist with the CBT; and iii) support the interaction between the students and CBT. Additionally, participants will be referred to a primary care clinic to receive treatment as usual.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Treatment as usual consists of identification and assisted referral to a primary care clinic where trained psychologists will assess the symptomatology and propose a course of actions, from initiation of psychotherapy to referral to a General practitioner to initiate medication if needed. Psychoterapy in primary care clinics consists of a range of 4-8 sessions twice a month. Most of the content of the psychotherapy are based on Cognitive-Behavioral Model. When needed, general practioners may suggest using medication, which normally are SSRI anditepressant (e.g., Fluoxetine, Sertraline). Medical check-up is conducted every month or every two months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Treatment as usual consists of identification and assisted referral to a primary care clinic where trained psychologists will assess the symptomatology and propose a course of actions, from initiation of psychotherapy to referral to a General practitioner to initiate medication if needed. Psychoterapy in primary care clinics consists of a range of 4-8 sessions twice a month. Most of the content of the psychotherapy are based on Cognitive-Behavioral Model. When needed, general practioners may suggest using medication, which normally are SSRI anditepressant (e.g., Fluoxetine, Sertraline). Medical check-up is conducted every month or every two months.
Study: NCT05810064

Intervention type: OTHER
Intervention: Falls-Risk Clinical Decision Support (CDS) Tool
Description: CDS in the Electronic Health Record (EHR) to screen patients at high-risk for future falls enabling referrals to the UW Health Mobility and Falls clinic.
Study: NCT05909956

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KinesioTape
Description: The kinesio tape technique, one of the physiotherapy techniques, is an elastic thin band, water-resistant, air-permeable framework to stimulate muscle movements, assist weak muscles (fascia and soft tissue), reduce discomfort and muscle cramps, facilitate proprioceptive input, boost lymph and blood flow, and relieve pain. Participants in the KT group will receive therapeutic tape on the sacral and suprapubic regions with the Star shape and ligament technique (From initial 4 h to 72 h of the menstruation cycle)

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Tape
Description: This group will receive KT tapping without stretch on the sacral and suprapubic region.

Intervention type: OTHER
Group type: OTHER
Intervention: General Physio session
Description: General physical therapy session including Hot pack (3-5min) and General body stretching(stretching of neck \& upper trapezius, arm \& shoulder girdle, triceps brachii, teres major \& minor, quadriceps muscle iliopsoas muscle, adductors muscle, hamstrings muscle) 30-45 sec each, for 7-10 min, (0-4 week) ,45-60sec each, for 10-15 min(4-8week), 15-20 min(8-12week) will be repeated 2 times/day.
Study: NCT05537597

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: active M1-rTMS
Description: Magnetic stimulation will be carried out using a MagPro X100 machine with a MCF-B70 figure-of-eight coil (Magventure, Farum). All rTMS sessions will be assisted by a neuronavigation system (TMS Navigator，Localite GmbH), maintaining the M1 target and the orientation of coil stable during stimulation sessions. The M1 target was defined as the hand knob region, which corresponds to the motor cortical representation of the hand, regardless of the location of pain.~Stimulation paradigm consists of 20 trains of pulses with an intra-train frequency of 20 Hz, resulting in 2000 pulses for a total duration of 20 minutes.~The stimulation intensity will be 80% of RMT, defined as the lowest stimulation intensity necessary to induce a visible muscle twitch of the hand contralateral to the stimulated hemisphere.~Participants will receive 7 sessions of treatment once a day in the same time continuously for 7 days, and keep antiparkinsonism drugs unchanged throughout the whole study.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham rTMS
Description: The sham protocol was similar to the rTMS protocol. Sham stimulations will be performed with a MCF-P-B65 figure-of-eight coil (Magventure) to M1, assisted by a neuronavigation system.~The following stimulation parameters will be used: stimulus frequency 20 Hz; stimulus intensity 80 % of RMT; total stimulation pulses 2,000; total stimulation time 20 min.~Participants will receive 7 sessions of treatment once a day in the same time continuously for 7 days, and keep antiparkinsonism drugs unchanged throughout the whole study.
Study: NCT04268121

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment
Description: 4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide followed by surgery or chemoradiotherapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant treatment
Description: Surgery (before study entry) followed by 4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide
Study: NCT04987333

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavaleukin alfa
Description: Administered as a single dose SC injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavaleukin alfa
Description: Administered as a single dose SC injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavaleukin alfa
Description: Administered as a single dose SC injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavaleukin alfa
Description: Administered as a single dose SC injection.
Study: NCT04930471

Intervention type: DRUG
Intervention: Metformin
Description: Treatment with Metformin as prescribed by the treating physician.
Study: NCT04772274

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ustekinumab
Description: 45 mg, single-dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Description: 45 mg, single-dose
Study: NCT04180293

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pilot psychoeducation program
Description: Canadian Armed Forces veterans and their family members will be recruited to participate in this pilot virtual psychoeducation program and its evaluation. Two six-week sessions will be implemented over a virtual care platform (Zoom for healthcare) based out of OSI Clinic in Atlantic Canada - the first in January/February of 2021 and the second in the spring of 2021. A maximum of 10-15 participants (including both veterans and their family members) will be recruited for each group. Family members are defined as spouses/partners, siblings, parents, and adult children. Each of the weekly sessions will take place virtually and will be led by at least two trained facilitators (one from the research team, and one member of the OSI clinical staff team). Each of these sessions will focus on providing education of different topics relevant to those accessing services at the clinic (e.g., types of treatments available, tools to support families, self care, etc.).

Intervention type: OTHER
Group type: OTHER
Intervention: Program evaluation
Description: At the end of each six-week session, program outcomes will be assessed qualitatively by a member of the research team. Participants will take part in semi-structured interviews guided by questions informed by the ecological family systems theory.
Study: NCT04916509

Intervention type: DRUG
Intervention: Palbociclib plus an aromatase inhibitor
Description: Palbociclib plus an aromatase inhibitor therapy
Study: NCT04772274

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ustekinumab
Description: 45 mg, single-dose
Study: NCT04636268

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FIB Grifols
Description: FIB Grifols is the IP and will be administered via slow intravenous (IV) infusion at a rate not to exceed 5 mL/minute.~Dosing will be individually calculated for each subject based on the target plasma fibrinogen level according to the type of bleeding, measured actual plasma fibrinogen level before infusion, and body weight. The IP will be administered according to the nominal potency of the product.
Study: NCT06405191

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web based education
Description: The link to the web page was shared with the students in the experimental group (https://inonuhemsirelikesaslari.com, the expired page cannot be accessed at the moment). Theoretical training and application process steps video for IV catheterization and IM injection skills were taken to the students in the experimental group and uploaded to the web page. The students in the experimental group were given a username-password with which they could access the web page, and the access status of the students was followed by the researcher. The researcher was able to see the frequency of each student watching the videos and their scores in online tests. The student who did not watch the videos or did not take the test was interviewed and feedback was given about watching them. Students were able to access the web page as often as they wanted for two weeks.
Study: NCT05279677

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation plus Sintilimab and Fruquintinib
Description: Microbiota capsules containing 1g gut microbiota, po d1-3 before anti-tumor treatment, total for 8 cycles.~Sintilimab 200mg iv, q3w. Fruquintinib 5mg po d1-14, q3w.
Study: NCT05623917

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-supervised diaphragmatic respiratory exercise
Description: the group will contain 20 females. the females will receive tele-supervised Diaphragmatic Respiratory Exercise ( applied at the homes of the females two times per the day, at the morning and at the evening, twenty minutes for every time, the sessions will be applied daily for 3 months in all females).
Study: NCT06416384

Intervention type: OTHER
Group type: OTHER
Intervention: Hand Massage Group
Description: The patients in the hand massage application group were asked by the researcher; Hand massage with olive oil was applied 12 times in total, three times a week for four weeks. No application was made to the side with fistula.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Patients in the control group received routine nursing care in the clinic for four weeks.
Study: NCT05463484

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test composition Saliactive® (olive product, betaine and xylitol)
Description: Fluoridated toothpaste with Saliactive®.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Fluoridated toothpaste without Saliactive®.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Commercial Fluoridated toothpaste for gingivitis with zinc citrate.
Study: NCT06299332

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device treatment
Description: 20 heterosexual males clinically diagnosed with Erectile Dysfunction will receive 6 weekly treatments with the Forma Applicator according to the study protocol and will return for two follow up visits 1- and 3-months post treatment. Two further telephone feedback checks will be carried out 6 months and 12 months following the last treatment visit
Study: NCT04916509

Intervention type: DRUG
Intervention: Palbociclib plus fulvestrant
Description: Palbociclib plus fulvestrant
Study: NCT04755634

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid
Description: Injectable
Study: NCT05558280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dinutuximab beta
Description: The study treatment will be administered with a continuous intravenous infusion at a dose of 14 mg/mq/day, days 1-5, a total of 60 hours (cumulative dose/cycle: 70 mg/mq). Each cycle lasts 28 days.The treatment phase foresees 5 cycles of Dinutuximab Beta.
Study: NCT04841707

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: uEXPLORER/mCT
Description: Each participant will undergo two 18F-FDG PET/CT scans, one at baseline and one at 4- month (+/- 2 weeks) follow-up.
Study: NCT04818684

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices

Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices
Study: NCT05348057

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivabradine
Description: The starting dose is 5 mg twice a day. Adjust the dose according to the actual situation
Study: NCT06053255

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
Description: HIFU is delivered via a non-invasive ultrasonic transducer, through a gel pad for acoustic coupling, into the patients body in a precise manner focused on the lateral sacral branch nerves.
Study: NCT05488587

Intervention type: DIAGNOSTIC_TEST
Intervention: magnesium and zinc levels
Description: measuring magnesium and zinc levels

Intervention type: DIAGNOSTIC_TEST
Intervention: magnesium and zinc levels
Description: measuring magnesium and zinc levels

Intervention type: DIAGNOSTIC_TEST
Intervention: magnesium and zinc levels
Description: measuring magnesium and zinc levels
Study: NCT05261958

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SAQ training
Description: interventions listed above were applied on the players which will improve running mechanics and impove speed power and agility in football players
Study: NCT05386992

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Anthropometric study
Description: Once the 5 models of lasts have been produced in phase 1, certain shoe models will be designed and manufactured based on these lasts at random and at the free choice of the designers of a footwear company. These models will then be physically tested on children to analyze their effects on walking and walking.
Study: NCT06091215

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sciton Joule System
Description: Sciton Joule System

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sciton Joule System
Description: Sciton Joule System
Study: NCT05120479

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: Kinesiotape (KT): KT will be placed without any extra tension (in the scientific literature it is called paper off tension). The measure determined in the measurement with a tape measure is cut. The anchor of the KT is placed on the medial epicondyle with the body segments in a neutral position (anchor length: 5 cm). Placement of the active zone of the bandage with the flexor muscles of the fingers in elongation. Origin-insertion placement. Distal anchor in neutral position. Material: Kinesiotape: Kinesiology Tape TEMTEX ® Beige (Towatek Korea Co .; South Korea).

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham tape
Description: Sham tape: exactly the same procedure is followed as above, but an adhesive inelastic tape is used. Material: Omnifix elastic (Laboratorios Hartmann S.A .; Spain).
Study: NCT06022731

Intervention type: DIAGNOSTIC_TEST
Intervention: Panoramic Radiography
Description: this retrospective study includes analysis of radiographs previously taken from patients for various purposes

Intervention type: DIAGNOSTIC_TEST
Intervention: Panoramic Radiography
Description: this retrospective study includes analysis of radiographs previously taken from patients for various purposes
Study: NCT05745220

Intervention type: OTHER
Group type: OTHER
Intervention: Device: silicone hydrogel contact lens
Description: Silicone hydrogel contact lens
Study: NCT06232070

Intervention type: DEVICE
Intervention: Lunit INSIGHT MMG
Description: In the Lunit Assisted arm, the radiographers will also be seeing the Lunit INSIGHT MMG reports while reading the mammograms. The standard of care will be followed in all the cases
Study: NCT05800548

Intervention type: OTHER
Intervention: survey application
Description: In data collection; Socio-demographic and obstetric characteristics of puerperant women, descriptive information form including questions about current birth, Postpartum Family Planning Attitude Scale The Health Literacy Scale was used.
Study: NCT05988658

Intervention type: DEVICE
Intervention: ESTOP - AKI 2.0
Description: Medical software as a Noninvasive medical device, which at the time of the project will not implement directly into subject/clinical care.